ACTU
Actuate Therapeutics
ACTU
ACTU
38 hedge funds and large institutions have $68.5M invested in Actuate Therapeutics in 2025 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 12 increasing their positions, 2 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less capital invested
Capital invested by funds: $70.4M → $68.5M (-$1.9M)
Holders
38
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.15M | |
| 2 | +$1.64M | |
| 3 | +$1.26M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$739K |
| 5 |
BCM
BIOS Capital Management
Fort Worth,
Texas
|
+$624K |
Top Sellers
| 1 | -$322K | |
| 2 | -$160K | |
| 3 | -$151K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$150K |
| 5 |
Mercer Global Advisors
Denver,
Colorado
|
-$111K |